14584001

Source:http://linkedlifedata.com/resource/pubmed/id/14584001

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0017661, umls-concept:C0021081, umls-concept:C1522326
pubmed:issue	4
pubmed:dateCreated	2003-10-29
pubmed:abstractText	IgA nephropathy (IgAN) is a world-wide disease and the cause of end-stage renal failure (ESRF) in 15 to 20% of patients within 10 years and in 30 to 40% of individuals within 20 years from the apparent onset of disease. No specific treatment has yet been established but many approaches have been investigated.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100909747
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents
pubmed:status	MEDLINE
pubmed:issn	1469-493X
pubmed:author	pubmed-author:CraigJ CJC, pubmed-author:MolonyD ADA, pubmed-author:SamuelsJ AJA, pubmed-author:SchenaF PFP, pubmed-author:StrippoliG F MGF
pubmed:issnType	Electronic
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	CD003965
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:14584001-Glomerulonephritis, IGA, pubmed-meshheading:14584001-Humans, pubmed-meshheading:14584001-Immunosuppressive Agents, pubmed-meshheading:14584001-Kidney Failure, Chronic, pubmed-meshheading:14584001-Randomized Controlled Trials as Topic
pubmed:year	2003
pubmed:articleTitle	Immunosuppressive agents for treating IgA nephropathy.
pubmed:affiliation	Nephrology / Pediatric Nephrology, UT-Houston Health Science Center, 6431 Fannin Street, MSB 4-148, Houston, TX 77030, USA. Joshua.A.Samuels@uth.tmc.edu
pubmed:publicationType	Journal Article, Review